Artax Biopharma

Developer of small molecules for the treatment of autoimmune and inflammatory diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups2 employees language artaxbiopharma.com

Registered entities

Social engagement

Social engagement: 2.5K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record; lead investors include Columbus Venture Partners, Lilly, Sound Bioventures, Advent Life Sciences.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%

Recent activity

8 Jun 2026
Event
BIO2026
27 May 2026
Event
BIO 2026
6 Jan 2026
Event
JPMWeek 2026
Coming soon